Clinical/scientific notes

Neurology: Neuroimmunology and NeuroInflammation

Volumn 1, Issue 3, 2014, Pages

  Merkler, Alexander E ^a   Prasad, Mukesh ^a   Lavi, Ehud ^a   Safdieh, Joseph ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ADULT; AGRAPHIA; ALEXIA; ATAXIA; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CREUTZFELDT JAKOB DISEASE; DYSARTHRIA; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; LEUKOCYTE COUNT; LOUDNESS RECRUITMENT; MALE; MIDDLE AGED; MYALGIA; NECK PAIN; NEUROIMAGING; NOTE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; WALKING DIFFICULTY;

EID: 85014596016     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000032     Document Type: Note

References (7)

1. Johnson RT. Prion diseases. Lancet Neurol 2005; 4: 635-642.
2. Orimo S, Ozawa E, Uematsu M., et al. A case of Creutzfeldt-Jakob disease presenting with auditory agnosia as an initial manifestation. Eur Neurol 2000; 44:256-258.
3. Krishna P, Bauer C. Hearing loss as the initial presentation of Creutzfeldt-Jakob disease. Ear Nose Throat J 2004; 83: 535, 538, 540 passim.
4. Tschampa HJ, Zerr I, Urbach H. Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol 2007; 17:1200-1211.
5. Steinhoff BJ, Räcker S, Herrendorf G., et al. Accuracy and reliability of periodic sharp wave complexes in CreutzfeldtJakob disease. Arch Neurol 1996; 53:162-166.
6. Hsich G, Kenney K, Gibbs C.J., Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335:924-930.
7. Krasnianski A, Meissner B, Schulz-Schaeffer W, et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006; 63: 876-880.